|
|
European Monitoring Centre for Drugs and Drug Addiction. (2003). Annual report 2003 : the state of the drugs problem in the European Union and Norway. Annual report. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; communicable disease; AODR mortality; prevalence; Europe; annual report
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2004). Annual report 2004: the state of the drugs problem in the European Union and Norway. Annual report. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; Europe; annual report
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2005). Annual report 2005 : the state of the drugs problem in Europe. Annual report. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; Europe; annual report
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2006). Annual report 2006 : the state of the drugs problem in Europe. Annual report. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; Europe; annual report
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (1998). 1998 Extended annual report on the state of the drugs problem in the European Union. Annual report. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; amphetamines; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; communicable disease; AODR mortality; Europe; annual report
|
|
|
|
International Antiprohibitionist League. (2003). World drugs report : 2003 update : a critical reading of publicly available information. Rome: International Antiprohibitionist League (IAL).
Keywords: political activism; monitoring; government and politics; laws and regulations; public policy on AOD; strategy; law enforcement; AOD use, abuse, and dependence; illicit drug; drug market; evaluation; statistical data; international area; Afghanistan; Myanmar
|
|
|
|
United Nations Office on Drugs and Crime. (2007). Opium poppy cultivation in South East Asia. Vienna: United Nations Office for Drug Control and Crime Prevention (UNODCCP).
Keywords: research; international area
|
|
|
|
United Nations Office on Drugs and Crime. (2008). Afghanistan : opium winter rapid assessment survey. Vienna: United Nations Office for Drug Control and Crime Prevention (UNODCCP).
Keywords: addiction; heroin; international area
|
|
|
|
United Nations Office on Drugs and Crime. (2007). Afghanistan : opium survey 2007. Vienna: United Nations Office for Drug Control and Crime Prevention (UNODCCP).
Keywords: addiction; heroin; international area
|
|
|
|
Expert Committee of the World Health Organization. (1999). International criticism of the Swiss heroin trials : report of the External Expert Committee of the WHO : statements of the UN International Narcotics Control Board (INCB). Zurich: Swiss Physicians against Drugs and AIDS Information Switzerland.
Keywords: treatment and maintenance; heroin-assisted treatment; prescription drug; evaluation; Switzerland
|
|
